Skip to main content

Doxepin topical Side Effects

Medically reviewed by Drugs.com. Last updated on May 30, 2023.

Applies to doxepin topical: topical cream.

Serious side effects of Doxepin topical

Along with its needed effects, doxepin topical may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor as soon as possible if any of the following side effects occur while taking doxepin topical:

More common

Rare

Symptoms of overdose

Other side effects of Doxepin topical

Some side effects of doxepin topical may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

For Healthcare Professionals

Applies to doxepin topical: topical cream.

Local

Very common (10% or more): Burning/stinging (23%)

Common (1% to 10%): Other application site reaction

Frequency not reported: Irritation, tingling[Ref]

Nervous system

Very common (10% or more): Drowsiness (up to 22%)

Common (1% to 10%): Dizziness, taste perversion

Uncommon (0.1% to 1%): Headache

Frequency not reported: Lightheadedness, taste bitter, taste metallic[Ref]

Gastrointestinal

Common (1% to 10%): Dry mouth

Uncommon (0.1% to 1%): Numbness of tongue, nausea

Frequency not reported: Dry lips, dry throat, thirst, indigestion, vomiting, diarrhea, constipation[Ref]

Dermatologic

Common (1% to 10%): Pruritus, eczema exacerbated

Frequency not reported: Localized rash, pruritus exacerbated

Postmarketing reports: Allergic contact dermatitis[Ref]

General

The most frequently reported adverse effects were drowsiness and burning/stinging at application site.[Ref]

Genitourinary

Frequency not reported: Urinary retention[Ref]

Hypersensitivity

Frequency not reported: Type IV hypersensitivity reaction[Ref]

Ocular

Frequency not reported: Blurred vision, dry eyes[Ref]

Other

Common (1% to 10%): Fatigue/tiredness, edema

Uncommon (0.1% to 1%): Fever

Frequency not reported: Vertigo[Ref]

Psychiatric

Common (1% to 10%): Mental emotional changes

Uncommon (0.1% to 1%): Nervousness/anxiety[Ref]

References

1. Product Information. Zonalon (doxepin topical). Bioglan Pharmaceutical Inc. 2001;PROD.

2. MHRA. Medicines and Health Regulatory Agency. MHRA Drug Safety Update. http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate 2013.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.